Decreased Ovarian Reserve
Conditions
Interventions
Fendomethon group:Fendomethon
Chinese Medicine and Fendomethon Group :Chinese Medicine and Fendomethon
A combination of acupuncture and medicine and Fendomethon Group :A combination of acupuncture and medicine and Fendomethon
Sponsors
Guang 'Anmen Hospital, Chinese Academy of Traditional Chinese medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 39 Years
Inclusion criteria
Inclusion criteria: ?according to the diagnostic standard of decline of Ovarian Reserve function in Western medicine and the diagnosis of deficiency of the kidney and stagnation of the Liver Syndrome in traditional Chinese Medicine; ? the age ranged from 20 to 39 years old; ? the patients did not take any hormone therapy in the last 3 months. ?those who voluntarily sign the informed consent form and can persist in treatment;
Exclusion criteria
Exclusion criteria: ?Age > 20 years old or > 39 years old;?Ovarian tumors, Pituitary Adenomas, polycystic ovary syndrome, Hyperprolactinaemia, congenital adrenal CORTEX, cushing's syndrome, thyroid dysfunction; ?patients with poor control of Blood Glucose, complicated with serious primary diseases such as heart, liver and kidney, psychotic patients;? those who were treated with hormone or combined with hormone or metabolic drugs within 3 months;? subjects who were enrolled in or had participated in other clinical trials within one month;? subjects who were known to be allergic to the drugs and had an allergic constitution; ? who did not meet the inclusion criteria and did not use the drugs as prescribed, unable to judge the efficacy or incomplete data affecting the efficacy or safety judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti-mullerian hormone(AMH);Sex Hormone levels(FSH\ LH\ E2);Number of Basic Antral follicle; | — |
Secondary
| Measure | Time frame |
|---|---|
| Integral of TCM Syndrome; | — |
Countries
China
Contacts
Public ContactMaLishuang
Outcome results
None listed